Last reviewed · How we verify
NCT03999398
Short and Long-term Results of PCI in no Touch Vein-graft.
trial testing Percutaneous coronary intervention (PCI) in Percutaneous Coronary Intervention in 260 participants. Status unknown.
1 January 2022
Quick facts
| Lead sponsor | Region Örebro County |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 260 |
| Start date | 1 October 2017 |
| Primary completion | 1 January 2022 |
| Estimated completion | 2 January 2022 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Percutaneous coronary intervention (PCI)
Conditions studied
- Percutaneous Coronary Intervention — all drugs for Percutaneous Coronary Intervention →
- Saphenous Vein — all drugs for Saphenous Vein →
- Coronary Artery Bypass — all drugs for Coronary Artery Bypass →
Sponsor
Region Örebro County — full company profile →
Who can join
Eligibility, any sex, with Percutaneous Coronary Intervention or Saphenous Vein. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Coronary artery disease is one of the biggest health issue worldwide.The treatment, in a large part of the patients, implicates a so called bypass-operation, that consists in to connect new vascular conduits (grafts) beyond the narrowed coronary vessels to improve the blood supply to the heart. One of the graft that is commonly used is the saphenous vein from the leg. The disadvantage of the saphenous vein graft is the predisposition to early obstruction. The international literature shows the following grades of occlusion: 15% in the first year and 40% after 10 year. At the Cardio-Thoracic Clinic of the University hospital of Örebro has been developed a new method to harvest the saphenous vein together with the surrounding fat-tissue. This technique, called no-touch technique, has the advantage to reduce the damages to the vein during the harvesting, showing a substantially reduced risk for future occlusion (5% after 18 months and 10% after 8,5 years). The aim of the PhD project is to evaluate the results of the no-touch technique in compare to the conventional technique for the venous graft harvesting. The focus of the study is to analyse all the operated patients in our clinic who underwent a post-operative coronary angiography do to angina pectoris (heart pain). All the patients who received a stent during the post-operative angiography will be analysed in detail and one will compare the occlusion grade and the rate of major adverse cardiac events (MACE). This study is the first and the only one in the world that will examine the long-term results of the no-touch technique in particular after the stenting of the venous graft.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Quality of Life After Percutaneous Coronary Intervention in No-Touch Saphenous Vein Grafts is Significantly Better Than in Conventional Vein Grafts.
Ferrari G, Karlsson J, Cao Y, Geijer H, et al · · 2022 · cited 5× · PMID 35976202 · DOI 10.21470/1678-9741-2021-0576 -
Long-term results of percutaneous coronary intervention in no-touch vein grafts are significantly better than in conventional vein grafts.
Ferrari G, Geijer H, Cao Y, Graf U, et al · · 2025 · cited 3× · PMID 38253348 · DOI 10.1177/02676591241230012
Verify or expand the search:
- PubMed search for NCT03999398
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Percutaneous coronary intervention (PCI)
Trials testing the same drug.
- NCT06399692 — REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women · Phase 3 · recruiting
- NCT07004569 — Angiolite Registry Study · recruiting
- NCT05645926 — Association of Obesity and Cardiovascular Outcomes in Myocardial Infarction · unknown
- NCT06397820 — Relation Between AI-QCA and Cardiac PET · completed
- NCT04252703 — 'MInimalist' or 'MOre Complete' Strategies for Revascularization in Octogenarians · NA · terminated
Other recruiting trials for Percutaneous Coronary Intervention
Currently open trials in the same condition.
- NCT07231939 — Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI · recruiting
- NCT07378163 — Study on the Preferences for PCI Implantation Devices Among Doctors and Patients · recruiting
- NCT07378137 — Comparing the Components of Composite Endpoints for Healthcare Providers and Patients · recruiting
- NCT06878729 — Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI · NA · recruiting
- NCT07446023 — IVUS-FFR Accuracy for Coronary Stenosis · NA · recruiting
Other Region Örebro County trials
Trials by the same sponsor.
- NCT07406750 — Hemodynamic Venous Congestion Ultrasound (VExUS) by ICU Nurses in Sepsis Patients. · not yet recruiting
- NCT07334132 — General Anaesthesia vs Spinal Anaesthesia: Patient Outcomes and Success in Outpatient Primary Total Knee and Hip Arthrop · Phase 4 · not yet recruiting
- NCT07158138 — A Digitally Distributed Yoga Intervention in Prostate Cancer Rehabilitation : Protocol for a Randomized Controlled Trial · NA · not yet recruiting
- NCT07206147 — Physical Exercise as Treatment Post-stroke Fatigue - a Feasibilty Study. · NA · not yet recruiting
- NCT07378566 — Intervention to Master Complex Fall Risk Situations in Persons With Multiple Sclerosis (STAR) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03999398 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Örebro County
- Last refreshed: 9 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03999398.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing